1. Home
  2. SGML vs VIR Comparison

SGML vs VIR Comparison

Compare SGML & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sigma Lithium Corporation

SGML

Sigma Lithium Corporation

N/A

Current Price

$12.86

Market Cap

1.4B

Sector

Industrials

ML Signal

N/A

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$11.55

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SGML
VIR
Founded
2011
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SGML
VIR
Price
$12.86
$11.55
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$18.75
$19.43
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$272.11
$270.22
Revenue Next Year
$36.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$4.75
52 Week High
$24.48
$11.94

Technical Indicators

Market Signals
Indicator
SGML
VIR
Relative Strength Index (RSI) 57.02 69.04
Support Level $11.64 $8.43
Resistance Level $13.25 $11.66
Average True Range (ATR) 0.63 0.60
MACD 0.12 0.19
Stochastic Oscillator 78.29 84.39

Price Performance

Historical Comparison
SGML
VIR

About SGML Sigma Lithium Corporation

Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: